Chemical Constituents from Solenostemma argel and their Cholinesterase Inhibitory Activity
Author(s) -
Rym Gouta Demmak,
Simon Bordage,
Abederrahmane Bensegueni,
Naima Boutaghane,
Thierry Hennebelle,
El Hassen Mokrani,
Sevser Şahpaz
Publication year - 2019
Publication title -
natural product sciences
Language(s) - English
Resource type - Journals
eISSN - 2288-9027
pISSN - 1226-3907
DOI - 10.20307/nps.2019.25.2.115
Subject(s) - butyrylcholinesterase , acetylcholinesterase , chemistry , cholinesterase , aché , stereochemistry , kaempferol , biochemistry , enzyme , pharmacology , flavonoid , biology , antioxidant
− Alzheimer’s disease is a chronic neurodegenerative disorder with no curative treatment. The commercially available drugs, which target acetylcholinesterase, are not satisfactory. The aim of this study was to investigate the cholinesterase inhibitory activity of Solenostemma argel aerial part. Eight compounds were isolated and identified by NMR: kaempferol-3-O-glucopyranoside (1), kaempferol (2), kaempferol-3-glucopyranosyl(1→6)rhamnopyranose (3) p-hydroxybenzoic acid (4), dehydrovomifoliol (5), 14,15-dihydroxypregn-4-ene-3,20-dione (6), 14,15-dihydroxy-pregn-4-ene-3,20-dione-15β-D-glucopyranoside (7) and solargin I (8). Two of them (compounds 2 and 3) could inhibit over 50 % of butyrylcholinesterase activity at 100 μM. Compound (2) displayed the highest inhibitory effect against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) with a slight selectivity towards the latter. Molecular docking studies supported the in vitro results and revealed that (2) had made several hydrogen and π-π stacking interactions which could explain the compound potency to inhibit AChE and BChE.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom